Clinical Trial

Effects of a Supervised Training Program on Functional Capacity in Patients With HF and Cardiorenal Syndrome

Study acronym: Train-CR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective study, blinded for the evaluator, randomized (1:1) to receive standard management alone or combined with a training program (aerobic combined with strength exercises) that will be carried out in a single center. After randomization, patients will be clinically evaluated. The primary endpoint (peakVO2) will be assessed by cardiopulmonary exercise testing combined with echocardiography (echo-CPET) at 12 weeks. Ambulatory patients with heart failure and cardiorenal syndrome and functional class NYHA II-III will be enrolled. A sample size estimation \[alfa: 0.05, power: 80%, a 20% loss rate, and at least a delta change of mean peakVO2: +2,4 mL/kg/min (SD±2)\] of 26 patients (13 per arm) would be necessary to test our hypothesis.
Trial Details
NCT Number NCT06640140
Lead Sponsor Fundación para la Investigación del Hospital Clínico de Valencia
Conditions Heart Failure, Cardiorenal Syndrome
Enrollment 26 participants
Start Date 2024-10-08
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-10-15